Nanjing Pharmaceutical Co., Ltd. (000919.SZ): The registration application for the dry suspension of levofloxacin carbonate has been accepted.

Zhijun Finance APP News, Jinling Pharmaceutical (000919.SZ) announced that the company's subsidiary Jinling Pharmaceutical Co., Ltd. Nanjing Jinling Pharmaceutical Factory recently received a acceptance notification for the suspension mixture of sevelamer carbonate issued by the National Medical Products Administration. Sevelamer carbonate is an insoluble polymer drug primarily used for the treatment of hyperphosphatemia in adult patients with chronic kidney disease (CKD) undergoing dialysis treatment.